3
14
Table 5. Nutrition Therapy for Very High TG
(≥500 mg/dL)/Chylomicron Clearing
15-20
Children and Adolescents
17
Table 6. Acceptable, Borderline-high, and High
Plasma Lipoprotein Lipids and Apolipoprotein
Concentrations for Children and Adolescents
18
Table 7. Major Risk Factors and Conditions in
Children and Adolescents
19
Figure 2. Dyslipidemia Algorithm Targeting LDL-C
from the 2011 Expert Integrated Guidelines for
Cardiovascular Health and Risk Reduction in
Children and Adolescents
20
Table 8. International Diabetes Federation's
Definition of the At Risk Group and Metabolic
Syndrome in Children and Adolescents
21-32
Special Populations
22
Women's Health
25
Older Patients
26
Ethnic Groups
30
Concurrent Conditions
33-37
Residual Risk After Statins and Lifestyle
Modification
34
Table 13. Significant Risk Indicators
35
Table 14. Recommendations
36
Table 15. Statin Combination Therapies
(clinical trial results)
37
Figure 3. Statin Combination Therapy
